LIFE SCIENCES

Achieving operational excellence is more than a strategy for those in the life sciences industry. It is a requirement of doing business. We can help streamline business processes and leverage technology to gain efficiency and stay competitive.

HOW WE SERVE THE LIFE SCIENCES INDUSTRY

Life Sciences companies best positioned for success are those that can increase operating efficiencies across Discovery, Clinical Operations, Supply Chain Management, Quality, Regulatory, and Finance. These efficiencies can be achieved by aligning strategic operating plans with cutting edge technology platforms. Archetype works with Life Sciences companies of all sizes and stages to enhance their ability to measure, report, and forecast their key business drivers, projections and results of operation.

Plan with Confidence

Ready access to business intelligence helps you develop a focused strategy and sustainable solutions. Spot and understand trends to work into your forecasts and improve accuracy.

Streamline Business Processes

Ensure workflows and processes are designed to leverage systems and technology for added value and savings.

Transform Operational Models

The weight of growing organizations can cause systems to clog. Optimize these systems and create views into your financial and operational processes to manage top and bottom-line growth.
0
Years
Avg. Time of Get Drug to Approval

Planning and forecasting tools must be calibrated to accommodate extended product life cycles and go-to-market timelines.

0
%
Avg return on R&D

Complete and accurate data is essential to mitigating risk and removing bottlenecks that can affect cycle times and budgets.

0
%
Life Sciences Execs

Percent concerned about integrating AI into business processes.  Barriers include lack of applicable skills, complexity and duration of implementations, and overall costs.

0
Billion
Avg. costs to develop new drugs

The estimated cost of getting a drug approved is three times higher since 2001. Drugmakers face even more costs after approval, and the average total could balloon to $2.9 billion.

Case Studies

How an Analysis of Current Processes Identified Need For a More Robust ERP
Life Sciences
How an Analysis of Current Processes Identified Need For a More Robust ERP
Discovery sessions answer question: How does my function bring value to the bottom-line?
Life Sciences
Discovery sessions answer question: How does my function bring value to the bottom-line?
Early adoption of cloud-based financial planning proves successful for biotech startup
Life Sciences
Early adoption of cloud-based financial planning proves successful for biotech startup
A global biopharmceutical company improves value and usability of existing Hyperion install
Life Sciences
A global biopharmceutical company improves value and usability of existing Hyperion install

Let us introduce ourselves

null

Candice Cantelli-Meklis

So What’s next?

Are You Ready?
Let’s Work!